{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:52:55Z","timestamp":1790981575451,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":51,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-026-03163-7","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T08:20:17Z","timestamp":1775031617000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association of the C-reactive protein\u2013triglyceride glucose index with all-cause and cardiovascular mortality among U.S. adults with metabolic dysfunction-associated steatotic liver disease: a national cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Ramin","family":"Assempoor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Jodeiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoo","family":"Javadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niloofar","family":"Seighali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Amir Seyed","family":"Shenava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimia","family":"Najafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Antoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Fatehi","family":"Hassanabad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Kuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tor","family":"Biering-S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian V.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaveh","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"issue":"6","key":"3163_CR1","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78(6):1966\u201386.","journal-title":"Hepatology"},{"issue":"4","key":"3163_CR2","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77(4):1335\u201347.","journal-title":"Hepatology"},{"issue":"3","key":"3163_CR3","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","volume":"79","author":"VW Wong","year":"2023","unstructured":"Wong VW, Ekstedt M, Wong GL, Hagstrom H. Changing epidemiology, global trends and implications for outcomes of NAFLD. J Hepatol. 2023;79(3):842\u201352.","journal-title":"J Hepatol"},{"issue":"Suppl","key":"3163_CR4","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.3350\/cmh.2022.0351","volume":"29","author":"P Konyn","year":"2023","unstructured":"Konyn P, Ahmed A, Kim D. Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease. Clin Mol Hepatol. 2023;29(Suppl):S43\u201357.","journal-title":"Clin Mol Hepatol"},{"issue":"1","key":"3163_CR5","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/s12933-024-02434-5","volume":"23","author":"H Zheng","year":"2024","unstructured":"Zheng H, Sechi LA, Navarese EP, Casu G, Vidili G. Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review. Cardiovasc Diabetol. 2024;23(1):346.","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"3163_CR6","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1016\/j.numecd.2024.04.018","volume":"34","author":"Y Yin","year":"2024","unstructured":"Yin Y, Zhu W, Xu Q. The systemic inflammation response index as a risk factor for hepatic fibrosis and long-term mortality among individuals with metabolic dysfunction-associated steatotic liver disease. Nutr Metab Cardiovasc Dis. 2024;34(8):1922\u201331.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"3163_CR7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12933-024-02572-w","volume":"24","author":"Y Qiao","year":"2025","unstructured":"Qiao Y, Wang Y, Chen C, Huang Y, Zhao C. Association between triglyceride-glucose (TyG) related indices and cardiovascular diseases and mortality among individuals with metabolic dysfunction-associated steatotic liver disease: a cohort study of UK Biobank. Cardiovasc Diabetol. 2025;24(1):12.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3163_CR8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/s12933-025-02941-z","volume":"24","author":"M Gan","year":"2025","unstructured":"Gan M, Chen B, Qin M, Zhang L, Wang X. Association between atherogenic index of plasma (AIP) and all-cause and cardiovascular mortality in patients with metabolic dysfunction-associated steatotic liver disease (MASLD): a cohort study based on NHANES 1999\u20132018. Cardiovasc Diabetol. 2025;24(1):391.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3163_CR9","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12933-025-02716-6","volume":"24","author":"Z Song","year":"2025","unstructured":"Song Z, Miao X, Liu S, Hu M, Xie X, Sun Y, Leng S. Associations between cardiometabolic indices and the onset of metabolic dysfunction-associated steatotic liver disease as well as its progression to liver fibrosis: a cohort study. Cardiovasc Diabetol. 2025;24(1):154.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3163_CR10","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s12933-025-02835-0","volume":"24","author":"Y Sun","year":"2025","unstructured":"Sun Y, Guo Y, Ma S, Mao Z, Meng D, Xuan K, Lu R, Pan X, Zhu X. Association of C-reactive protein-triglyceride glucose index with the incidence and mortality of cardiovascular disease: a retrospective cohort study. Cardiovasc Diabetol. 2025;24(1):313.","journal-title":"Cardiovasc Diabetol"},{"key":"3163_CR11","doi-asserted-by":"publisher","first-page":"905266","DOI":"10.3389\/fendo.2022.905266","volume":"13","author":"GT Ruan","year":"2022","unstructured":"Ruan GT, Xie HL, Zhang HY, Liu CA, Ge YZ, Zhang Q, Wang ZW, Zhang X, Tang M, Song MM, et al. A Novel Inflammation and Insulin Resistance Related Indicator to Predict the Survival of Patients With Cancer. Front Endocrinol (Lausanne). 2022;13:905266.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"3163_CR12","doi-asserted-by":"publisher","first-page":"24687","DOI":"10.1038\/s41598-025-10184-x","volume":"15","author":"N Tang","year":"2025","unstructured":"Tang N, Chen X, Li H, Cheng S, Hu Y, Wang L, Zhou Q, Zhang Q, Hao J, Qi C. Association of C reactive protein triglyceride glucose index with mortality in coronary heart disease and type 2 diabetes from NHANES data. Sci Rep. 2025;15(1):24687.","journal-title":"Sci Rep"},{"issue":"1","key":"3163_CR13","doi-asserted-by":"publisher","first-page":"26363","DOI":"10.1038\/s41598-025-08389-1","volume":"15","author":"N Cheng","year":"2025","unstructured":"Cheng N, Ma Z, Chen Y, Jin L, Chen L. C-reactive protein-triglyceride glucose index and heart failure in US adults from NHANES 2001\u20132010. Sci Rep. 2025;15(1):26363.","journal-title":"Sci Rep"},{"issue":"1","key":"3163_CR14","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12933-025-02876-5","volume":"24","author":"Y Chen","year":"2025","unstructured":"Chen Y, Jia W, Guo J, Yang H, Sheng X, Wei L, Li J. Association between the C-reactive protein-triglyceride glucose index and new-onset coronary heart disease among metabolically heterogeneous individuals. Cardiovasc Diabetol. 2025;24(1):316.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3163_CR15","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s12876-025-03870-7","volume":"25","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Lin H, Weng X, Dai H, Xu J. Correlation between hs-CRP-triglyceride glucose index and NAFLD and liver fibrosis. BMC Gastroenterol. 2025;25(1):252.","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"3163_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/apt.13012","volume":"41","author":"CE Ruhl","year":"2015","unstructured":"Ruhl CE, Everhart JE. Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey. Aliment Pharmacol Ther. 2015;41(1):65\u201376.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"3163_CR17","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12933-025-02686-9","volume":"24","author":"G Huo","year":"2025","unstructured":"Huo G, Tang Y, Liu Z, Cao J, Yao Z, Zhou D. Association between C-reactive protein-triglyceride glucose index and stroke risk in different glycemic status: insights from the China Health and Retirement Longitudinal Study (CHARLS). Cardiovasc Diabetol. 2025;24(1):142.","journal-title":"Cardiovasc Diabetol"},{"issue":"Suppl 1","key":"3163_CR18","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.2337\/dc21-S002","volume":"44","author":"A American Diabetes","year":"2021","unstructured":"American Diabetes A. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S15\u201333.","journal-title":"Diabetes Care"},{"issue":"1","key":"3163_CR19","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12933-025-02618-7","volume":"24","author":"L Jiang","year":"2025","unstructured":"Jiang L, Zhu T, Song W, Zhai Y, Tang Y, Ruan F, Xu Z, Li L, Fu X, Liu D, et al. Assessment of six insulin resistance surrogate indexes for predicting stroke incidence in Chinese middle-aged and elderly populations with abnormal glucose metabolism: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):56.","journal-title":"Cardiovasc Diabetol"},{"key":"3163_CR20","doi-asserted-by":"crossref","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE Jr., Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2018;138(17):e426\u2013e483.","DOI":"10.1161\/CIR.0000000000000597"},{"issue":"13","key":"3163_CR21","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1093\/eurjpc\/zwaf248","volume":"32","author":"X Ding","year":"2025","unstructured":"Ding X, Tian J, Chang X, Liu J, Wang G. Association between remnant cholesterol and the risk of cardiovascular-kidney-metabolic syndrome progression: insights from the China health and retirement longitudinal study. Eur J Prev Cardiol. 2025;32(13):1157\u201365.","journal-title":"Eur J Prev Cardiol"},{"issue":"19","key":"3163_CR22","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, Crews DC, Doria A, Estrella MM, Froissart M, et al. New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. N Engl J Med. 2021;385(19):1737\u201349.","journal-title":"N Engl J Med"},{"issue":"10","key":"3163_CR23","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","volume":"7","author":"AG Shah","year":"2009","unstructured":"Shah AG, Lydecker A, Murray K, Tetri BN, Contos MJ, Sanyal AJ. Nash Clinical Research N: Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2009;7(10):1104\u201312.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"3163_CR24","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1186\/s12933-025-03021-y","volume":"24","author":"X Shao","year":"2025","unstructured":"Shao X, Tan Z, Sun L, Fu Y, Chen A, Chen J, Bai G, Zhang J. Association between triglyceride-glucose index combined with a body shape index and atherosclerotic cardiovascular disease risk varies by glycemic status: insights from the UK Biobank. Cardiovasc Diabetol. 2025;24(1):456.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3163_CR25","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12933-024-02343-7","volume":"23","author":"Q Chen","year":"2024","unstructured":"Chen Q, Hu P, Hou X, Sun Y, Jiao M, Dai Pl, Yin Z, Liu X, Li R. Association between triglyceride-glucose related indices and mortality among individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease. Cardiovasc Diabetol. 2024;23(1):232.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3163_CR26","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12933-024-02287-y","volume":"23","author":"Y Min","year":"2024","unstructured":"Min Y, Wei X, Wei Z, Song G, Zhao X, Lei Y. Prognostic effect of triglyceride glucose-related parameters on all-cause and cardiovascular mortality in the United States adults with metabolic dysfunction-associated steatotic liver disease. Cardiovasc Diabetol. 2024;23(1):188.","journal-title":"Cardiovasc Diabetol"},{"key":"3163_CR27","first-page":"101135","volume":"49","author":"G He","year":"2024","unstructured":"He G, Zhang Z, Wang C, Wang W, Bai X, He L, Chen S, Li G, Yang Y, Zhang X, et al. Association of the triglyceride-glucose index with all-cause and cause-specific mortality: a population-based cohort study of 3.5 million adults in China. Lancet Reg Health West Pac. 2024;49:101135.","journal-title":"Lancet Reg Health West Pac"},{"issue":"1","key":"3163_CR28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12933-025-02620-z","volume":"24","author":"C Fang","year":"2025","unstructured":"Fang C, Peng N, Cheng J, Zhang X, Gu W, Zhu Z, Yin X, Yan Z, Zhang J, Yu P, et al. The association between TyG index and cardiovascular mortality is modified by antidiabetic or lipid-lowering agent: a prospective cohort study. Cardiovasc Diabetol. 2025;24(1):65.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"3163_CR29","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","volume":"73","author":"G Targher","year":"2024","unstructured":"Targher G, Byrne CD, Tilg H. MASLD: a systemic metabolic disorder with cardiovascular and malignant complications. Gut. 2024;73(4):691\u2013702.","journal-title":"Gut"},{"issue":"1","key":"3163_CR30","doi-asserted-by":"publisher","first-page":"21464","DOI":"10.1038\/s41598-025-06770-8","volume":"15","author":"G Liu","year":"2025","unstructured":"Liu G, Zheng R, Zeng Q, Li S, An Z. Combined association of triglyceride-glucose index and systemic inflammation index on all-cause and cardiovascular mortality. Sci Rep. 2025;15(1):21464.","journal-title":"Sci Rep"},{"issue":"1","key":"3163_CR31","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12933-024-02244-9","volume":"23","author":"C Cui","year":"2024","unstructured":"Cui C, Liu L, Qi Y, Han N, Xu H, Wang Z, Shang X, Han T, Zha Y, Wei X, et al. Joint association of TyG index and high sensitivity C-reactive protein with cardiovascular disease: a national cohort study. Cardiovasc Diabetol. 2024;23(1):156.","journal-title":"Cardiovasc Diabetol"},{"issue":"10","key":"3163_CR32","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1080\/01635581.2023.2273577","volume":"75","author":"DF Zhao","year":"2023","unstructured":"Zhao DF. Value of C-Reactive Protein-Triglyceride Glucose Index in Predicting Cancer Mortality in the General Population: Results from National Health and Nutrition Examination Survey. Nutr Cancer. 2023;75(10):1934\u201344.","journal-title":"Nutr Cancer"},{"key":"3163_CR33","doi-asserted-by":"crossref","unstructured":"Baek SU, Yoon JH. High-sensitivity C-reactive protein levels in metabolic dysfunction-associated steatotic liver disease (MASLD), metabolic alcohol-associated liver disease (MetALD), and alcoholic liver disease (ALD) with metabolic dysfunction. Biomolecules. 2024;14(11).2024 Nov 18;14(11):1468.","DOI":"10.3390\/biom14111468"},{"issue":"1","key":"3163_CR34","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s12933-025-02869-4","volume":"24","author":"X Ma","year":"2025","unstructured":"Ma X, Ma X, Wang Y, Qiu G, Zhang C. Associations of cumulative exposure and dynamic trajectories of the C-reactive protein-triglyceride-glucose index with incident cardiovascular disease in middle-aged and older Chinese adults: a nationwide cohort study. Cardiovasc Diabetol. 2025;24(1):303.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3163_CR35","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12944-017-0572-9","volume":"16","author":"Z Chen","year":"2017","unstructured":"Chen Z, Yu R, Xiong Y, Du F, Zhu S. A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease. Lipids Health Dis. 2017;16(1):203.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"3163_CR36","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1186\/s12933-025-02960-w","volume":"24","author":"L Zhang","year":"2025","unstructured":"Zhang L, Li S, Liu D, Gui J, Hu J, Wang Q, Mao W. The relationship between C-reactive protein-triglyceride-glucose index and cardiovascular disease: insights from the China health and retirement longitudinal study (CHARLS). Cardiovasc Diabetol. 2025;24(1):410.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3163_CR37","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1186\/s13098-025-01947-7","volume":"17","author":"Q Ying","year":"2025","unstructured":"Ying Q, He F, Wu L, Wei Q, Xu J. C-reactive protein-triglyceride glucose index predicts mortality in cardiovascular-kidney-metabolic syndrome stage 0\u20133: a prospective cohort study. Diabetol Metab Syndr. 2025;17(1):382.","journal-title":"Diabetol Metab Syndr"},{"issue":"11","key":"3163_CR38","doi-asserted-by":"publisher","first-page":"e16098","DOI":"10.14814\/phy2.16098","volume":"12","author":"SM Cornish","year":"2024","unstructured":"Cornish SM, Cordingley DM. Inflammatory pathway communication with skeletal muscle-Does aging play a role? A topical review of the current evidence. Physiol Rep. 2024;12(11):e16098.","journal-title":"Physiol Rep"},{"key":"3163_CR39","doi-asserted-by":"crossref","unstructured":"Palmer AK, Jensen MD. Metabolic changes in aging humans: current evidence and therapeutic strategies. J Clin Invest. 2022;132(16).2022 Aug 15;132(16):e158451.","DOI":"10.1172\/JCI158451"},{"issue":"8","key":"3163_CR40","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/j.1751-7176.2012.00647.x","volume":"14","author":"AD Sumner","year":"2012","unstructured":"Sumner AD, Sardi GL, Reed JF. 3rd: Components of the metabolic syndrome differ between young and old adults in the US population. J Clin Hypertens (Greenwich). 2012;14(8):502\u20136.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"10","key":"3163_CR41","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","volume":"14","author":"C Franceschi","year":"2018","unstructured":"Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018;14(10):576\u201390.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"3163_CR42","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1038\/s41467-022-30646-4","volume":"13","author":"MA Cottam","year":"2022","unstructured":"Cottam MA, Caslin HL, Winn NC, Hasty AH. Multiomics reveals persistence of obesity-associated immune cell phenotypes in adipose tissue during weight loss and weight regain in mice. Nat Commun. 2022;13(1):2950.","journal-title":"Nat Commun"},{"key":"3163_CR43","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3389\/fphys.2020.00824","volume":"11","author":"J Steppan","year":"2020","unstructured":"Steppan J, Jandu S, Savage W, Wang H, Kang S, Narayanan R, Nyhan D, Santhanam L. Restoring Blood Pressure in Hypertensive Mice Fails to Fully Reverse Vascular Stiffness. Front Physiol. 2020;11:824.","journal-title":"Front Physiol"},{"issue":"4","key":"3163_CR44","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.bbrc.2010.04.031","volume":"395","author":"T Mita","year":"2010","unstructured":"Mita T, Goto H, Azuma K, Jin WL, Nomiyama T, Fujitani Y, Hirose T, Kawamori R, Watada H. Impact of insulin resistance on enhanced monocyte adhesion to endothelial cells and atherosclerogenesis independent of LDL cholesterol level. Biochem Biophys Res Commun. 2010;395(4):477\u201383.","journal-title":"Biochem Biophys Res Commun"},{"key":"3163_CR45","doi-asserted-by":"publisher","first-page":"666","DOI":"10.3389\/fphar.2019.00666","volume":"10","author":"MC Flynn","year":"2019","unstructured":"Flynn MC, Pernes G, Lee MKS, Nagareddy PR, Murphy AJ. Monocytes, Macrophages, and Metabolic Disease in Atherosclerosis. Front Pharmacol. 2019;10:666.","journal-title":"Front Pharmacol"},{"issue":"1","key":"3163_CR46","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2010.12.008","volume":"13","author":"RG Baker","year":"2011","unstructured":"Baker RG, Hayden MS, Ghosh S. NF-kappaB, inflammation, and metabolic disease. Cell Metab. 2011;13(1):11\u201322.","journal-title":"Cell Metab"},{"issue":"5","key":"3163_CR47","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1161\/01.ATV.0000160340.72641.87","volume":"25","author":"MP de Winther","year":"2005","unstructured":"de Winther MP, Kanters E, Kraal G, Hofker MH. Nuclear factor kappaB signaling in atherogenesis. Arterioscler Thromb Vasc Biol. 2005;25(5):904\u201314.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"3163_CR48","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/s41419-023-06206-z","volume":"14","author":"P Hou","year":"2023","unstructured":"Hou P, Fang J, Liu Z, Shi Y, Agostini M, Bernassola F, Bove P, Candi E, Rovella V, Sica G, et al. Macrophage polarization and metabolism in atherosclerosis. Cell Death Dis. 2023;14(10):691.","journal-title":"Cell Death Dis"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03163-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03163-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03163-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T02:02:43Z","timestamp":1779415363000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03163-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3163"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03163-7","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"28 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research protocol for NHANES was officially approved by the Institutional Review Board of the National Center for Health Statistics (NCHS IRB). All participants provided informed written consent. As this study utilizes secondary analysis of deidentified, publicly accessible data from NHANES, it was exempt from additional review by the institutional review board according to the standards for secondary data analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"162"}}